What Fredun Pharma promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q1 FY27

what the last two calls moved 22 tracked 1 delivered 3 missed 18 open

Finance Cost delivered said Q3 FY26 Promised: Decline over the next 2 to 3 quarters Q1 FY27: Management confirmed that interest costs are 'slowly reducing' due to improved cash flows and a credit rating upgrade to BBB+, fulfilling the promise made in Q3 FY26.
Fredun Gx Revenue missed said Q1 FY26 Promised: INR 85 crores this year (FY26) Q1 FY27: Promise related to FY26 performance, which was missed. No new update.
Total Revenue revised up said Q1 FY26 Promised: Double revenue to INR 800+ crores in next 3-4 years Q1 FY27: Management now expects to cross INR 800 cr in FY27, significantly accelerating the original 3-4 year timeline.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 22 tracked commitments for Fredun Pharma — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens